Hospital
Flushing Hospital & Medical Center
Flushing Hospital & Medical Center was paid $18.18M by Medicaid between Jan 2018 and Dec 2024, across 155 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 17% of everything it billed.
33Billing provider infoFLUSHING HOSPITAL & MEDICAL CENTER
FLUSHING, NY 11355
FLUSHING, NY 11355
33aNPI1548217763assigned 05/31/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$18.18M
24GClaims286,064
24DCodes billed155
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in New York
Rank by total paid#64 of 231
Median peer was paid$561K
This provider vs. median32×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 27,176 | $1.44M | |
| 2019 | 40,008 | $1.98M | |
| 2020 | 38,730 | $2.23M | |
| 2021 | 42,815 | $2.77M | |
| 2022 | 35,487 | $3.07M | |
| 2023 | 59,505 | $4.10M | |
| 2024incomplete | 42,343 | $2.58M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 17% | 38,634 | 35,201 | $3.03M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 16% | 36,164 | 35,429 | $2.98M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 11% | 18,083 | 17,810 | $2.09M |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 9.0% | 10,548 | 5,076 | $1.64M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 6.5% | 17,230 | 15,682 | $1.18M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4.4% | 12,126 | 11,897 | $801K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3.9% | 10,500 | 10,492 | $707K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.2% | 9,822 | 8,648 | $576K |
| 96361 | Intravenous infusion, hydration; each additional hour | 2.2% | 1,321 | 1,279 | $399K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | 2.0% | 9,898 | 5,890 | $373K |
| 99460 | 1.8% | 3,354 | 3,333 | $319K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.7% | 3,049 | 2,900 | $317K |
143 more codes
| 99232 | Hospital visit by a doctor, follow-up day | 1.7% | 4,306 | $315K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.7% | 6,528 | $314K |
| 99221 | 1.5% | 3,660 | $279K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.4% | 4,320 | $250K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.3% | 1,835 | $233K |
| 99238 | Hospital discharge day management, 30 minutes or less | 1.2% | 2,822 | $219K |
| 99285 | Emergency room visit (most serious) | 1.0% | 1,217 | $191K |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,117 | $178K |
| 88307 | <1% | 1,657 | $165K | |
| 80053 | Comprehensive metabolic panel | <1% | 3,749 | $153K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 411 | $120K |
| 97803 | <1% | 1,809 | $110K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 1,741 | $104K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 2,314 | $101K |
| 99381 | <1% | 1,608 | $92K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 732 | $69K |
| 86850 | <1% | 1,139 | $65K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,473 | $63K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 851 | $57K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 711 | $55K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 382 | $47K |
| 99462 | <1% | 1,101 | $45K | |
| 97802 | <1% | 360 | $40K | |
| 81025 | <1% | 2,406 | $37K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 600 | $33K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 320 | $32K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 653 | $28K |
| 88304 | <1% | 1,722 | $26K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 982 | $25K |
| 86901 | <1% | 1,147 | $24K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 126 | $21K |
| 90677 | <1% | 228 | $19K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 325 | $19K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 56 | $19K |
| 86900 | <1% | 1,140 | $18K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 116 | $14K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 87 | $11K |
| 90686 | <1% | 552 | $11K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 51 | $10K |
| 76820 | <1% | 843 | $9K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 206 | $8K |
| T1013 | Sign language or oral interpretive services, per 15 minutes | <1% | 641 | $8K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 792 | $7K |
| 85610 | <1% | 2,056 | $7K | |
| J2704 | Injection, propofol, 10 mg | <1% | 2,087 | $7K |
| 80050 | General health panel | <1% | 193 | $6K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 4,878 | $6K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 303 | $6K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,721 | $5K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,703 | $5K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 142 | $5K |
| H2010 | Comprehensive medication services, per 15 minutes | <1% | 337 | $5K |
| 99442 | <1% | 149 | $5K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,800 | $4K |
| 90670 | <1% | 203 | $4K | |
| 80061 | Lipid panel | <1% | 272 | $4K |
| 85730 | <1% | 1,895 | $4K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 135 | $3K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 183 | $2K |
| 90656 | <1% | 91 | $2K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 112 | $2K |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 716 | $2K |
| 83655 | <1% | 169 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,605 | $2K |
| 90715 | <1% | 53 | $2K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,406 | $2K |
| 71045 | Radiologic examination, chest; single view | <1% | 787 | $2K |
| 80076 | <1% | 107 | $1K | |
| 0001A | <1% | 29 | $1K | |
| 90697 | <1% | 52 | $1K | |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | <1% | 257 | $1K |
| 90681 | <1% | 46 | $1K | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 550 | $1K |
| 99441 | <1% | 48 | $1K | |
| 0002A | <1% | 22 | $1K | |
| 98967 | <1% | 68 | $910.05 | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 193 | $833.56 |
| 90648 | <1% | 46 | $821.10 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 703 | $792.61 |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 15 | $767.72 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 954 | $755.55 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 188 | $751.44 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,811 | $723.65 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 26 | $715.47 |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 16 | $649.61 |
| 98968 | <1% | 22 | $592.23 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 389 | $559.87 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 548 | $556.71 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,230 | $517.82 |
| 90723 | <1% | 26 | $464.10 | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 13 | $459.89 |
| 92002 | <1% | 15 | $444.18 | |
| 99051 | <1% | 35 | $414.30 | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | <1% | 73 | $386.63 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 182 | $365.23 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 26 | $356.00 |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 14 | $336.93 |
| 88302 | <1% | 48 | $336.42 | |
| 90698 | <1% | 12 | $301.20 | |
| 81001 | <1% | 1,884 | $284.01 | |
| 99402 | <1% | 13 | $272.00 | |
| 87088 | <1% | 1,119 | $234.29 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 457 | $218.59 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 905 | $141.04 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 26 | $134.40 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 50 | $105.20 |
| 82550 | <1% | 710 | $100.58 | |
| 84484 | <1% | 891 | $94.47 | |
| 83735 | <1% | 379 | $91.69 | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 13 | $70.74 |
| 83605 | <1% | 355 | $67.07 | |
| Q3014 | Telehealth originating site facility fee | <1% | 13 | $63.03 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 87 | $57.92 |
| 84702 | <1% | 29 | $45.15 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 26 | $43.93 |
| 86140 | <1% | 158 | $42.07 | |
| 81003 | <1% | 199 | $40.59 | |
| 85027 | <1% | 336 | $37.75 | |
| 82947 | <1% | 562 | $34.48 | |
| 85007 | <1% | 319 | $33.76 | |
| 86592 | <1% | 52 | $21.14 | |
| 83690 | <1% | 1,036 | $19.29 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 52 | $16.53 |
| 82150 | <1% | 407 | $13.94 | |
| 87040 | <1% | 70 | $9.76 | |
| 87070 | <1% | 72 | $9.57 | |
| 84100 | <1% | 102 | $9.48 | |
| 86803 | <1% | 27 | $5.28 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 41 | $2.18 |
| 1126F | 0% | 1,326 | $0.00 | |
| 1036F | 0% | 3,701 | $0.00 | |
| 94761 | 0% | 1,370 | $0.00 | |
| 80320 | 0% | 233 | $0.00 | |
| 1125F | 0% | 126 | $0.00 | |
| 94760 | 0% | 252 | $0.00 | |
| G8732 | No documentation of pain assessment, reason not given | 0% | 242 | $0.00 |
| 88720 | 0% | 37 | $0.00 | |
| 82553 | 0% | 13 | $0.00 | |
| G0378 | Hospital observation service, per hour | 0% | 12 | $0.00 |
| 1159F | 0% | 2,171 | $0.00 | |
| 1160F | 0% | 1,731 | $0.00 | |
| 87400 | 0% | 110 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 25 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDOSS, MOUNIR (CFO)
| Provider | Location | Paid |
|---|---|---|
| Jamaica Hospital | Richmond Hill, NY | $178.14M |
| Flushing Hospital & Medical Center | Flushing, NY | $52.79M |
| Jamaica Hospital | Jamaica, NY | $37.88M |
| Jamaica Hospital | Jamaica, NY | $27.88M |
| Advanced Center for Psychotherapy, INC. | Jamaica, NY | $15.08M |
| Jamaica Hospital Medical Center | Jamaica, NY | $1.42M |
| Medisys Ambulance Service INC | Jamaica, NY | $1.38M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.